90 related articles for article (PubMed ID: 21802761)
1. Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: a time-series analysis for France 1998-2010.
Pichetti S; Sorasith C; Sermet C
Health Policy; 2011 Oct; 102(2-3):159-69. PubMed ID: 21802761
[TBL] [Abstract][Full Text] [Related]
2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive evaluation of rationality of cough and cold medicines available in Indian market.
Desai P; Patel S; Shah R; Desai S
J Indian Med Assoc; 2013 Feb; 111(2):94-8. PubMed ID: 24003565
[TBL] [Abstract][Full Text] [Related]
4. [Prescription of systemic cold and cough drugs to children 0-13 years old. An unresolved problem].
Cano Garcinuño A; Casares Alonso I; Rodríguez Barbero J; Pérez García I; Blanco Quirós A
An Pediatr (Barc); 2013 Jan; 78(1):43-50. PubMed ID: 22658583
[TBL] [Abstract][Full Text] [Related]
5. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
6. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
7. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
8. Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries.
Thomson S; Mossialos E
Issue Brief (Commonw Fund); 2010 Mar; 82():1-14. PubMed ID: 20411629
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of the impact of a positive list system on new chemical entity drugs and incrementally modified drugs in South Korea.
Ha D; Choi Y; Kim DU; Chung KH; Lee EK
Clin Ther; 2011 Jul; 33(7):926-32. PubMed ID: 21715008
[TBL] [Abstract][Full Text] [Related]
10. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
[TBL] [Abstract][Full Text] [Related]
11. The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada.
Hanley GE; Morgan S; Barer M; Reid RJ
Health Policy; 2011 Jul; 101(2):185-94. PubMed ID: 21255859
[TBL] [Abstract][Full Text] [Related]
12. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
Chen LC; Schafheutle EI; Noyce PR
Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
[TBL] [Abstract][Full Text] [Related]
13. Pricing and reimbursement of pharmaceuticals in Italy.
Folino-Gallo P; Montilla S; Bruzzone M; Martini N
Eur J Health Econ; 2008 Aug; 9(3):305-10. PubMed ID: 18566845
[TBL] [Abstract][Full Text] [Related]
14. [Effects of health-service reform in the field of medicinal drugs I. Analysis from the standpoint of a pharmacy].
Macesková B; Streitová J
Ceska Slov Farm; 2011 Jun; 60(3):99-104. PubMed ID: 21838138
[TBL] [Abstract][Full Text] [Related]
15. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
[TBL] [Abstract][Full Text] [Related]
16. Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses.
Rodbard HW; Green AJ; Fox KM; Grandy S;
Diabetes Res Clin Pract; 2010 Mar; 87(3):360-5. PubMed ID: 20047768
[TBL] [Abstract][Full Text] [Related]
17. The effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith DG
Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
[TBL] [Abstract][Full Text] [Related]
18. Surprising ways to cut your drug costs: even with insurance you might be paying too much.
Consum Rep; 2013 Sep; 78(9):26-30. PubMed ID: 23930299
[No Abstract] [Full Text] [Related]
19. Commercial importation of prescription drugs in the United States: short-run implications.
Danzon PM; Johnson SJ; Long G; Furukawa MF
J Health Polit Policy Law; 2011 Apr; 36(2):295-316. PubMed ID: 21543707
[TBL] [Abstract][Full Text] [Related]
20. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
Fise T
Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
